Skip to main content

Table 1 Patients’ basic characteristics

From: An individualized immune prognostic signature in lung adenocarcinoma

  No. of patients (n = 1337)
Affymetrix® platform
 GPL570 520 (38.89%)
 GPL96 436 (32.61%)
 GPL10379 381 (28.50%)
Age (years),mean(sd) 65.20 (10.01)
Sex ratio (M: F) 657:680
Stage
 I 753 (56.32%)
 II 428 (32.01%)
 III 138 (10.32%)
 IV 18 (1.35%)
Purity, mean (SD) 0.50 (0.15)